SCM
QDEL icon

Simcoe Capital Management’s QuidelOrtho QDEL Stock Holding History

Simcoe Capital Management’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-74,970
Closed -$8.43M – 19
2022
Q1 		$8.43M Buy
+74,970
New +$7.99M 1.01% 15

Other funds holding QDEL

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Simcoe Capital Management's QDEL Position: Q2 2022 in Review

Simcoe Capital Management sold out of QuidelOrtho (QDEL) in Q2 2022, closing a stake of 74,970 shares — an estimated $8.43M sold.

Simcoe Capital Management first reported a position in QDEL in Q1 2022 and held it in 1 quarter. The position peaked at $8.43M in Q1 2022. 347 funds tracked by Wall St. Rank hold QDEL as of Q2 2022.

  • Simcoe Capital Management reported no remaining QuidelOrtho position as of Q2 2022 after selling out during the quarter.
  • Simcoe Capital Management sold 74,970 QuidelOrtho shares in Q2 2022, an estimated $8.43M.
  • Simcoe Capital Management first reported a position in QuidelOrtho in Q1 2022 and held it in 1 quarter.
  • Simcoe Capital Management's QuidelOrtho position peaked at $8.43M in Q1 2022.
  • 347 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2022.

Based on Simcoe Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.